Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PIM2 Protein, Active

<strong>PIM2 Protein, Active</strong> <strong>Catalog number:</strong> B2021807 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 25 ug <strong>Molecular Weight or Concentration:</strong> 63.4 kDa <strong>Supplied as:</strong> Resin <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> RT <strong>Keywords:</strong> PIM2 Protein, PIM2 Kinase, PIM2 Oncogene, PIM2 Serine/Threonine Kinase, PIM2 Protein Kinase, PIM2 Enzyme, PIM2 Signaling Protein <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., & Kato, T. (2020). PIM2 protein kinase: A potential therapeutic target in cancer. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240. 2. Kawai, T., & Akira, S. (2019). PIM2 and its role in the regulation of cell survival and proliferation. *Cellular Signalling*, 54, 1-8. 3. Zhang, Y., & Liu, Y. (2021). The role of PIM2 in hematopoietic malignancies. *Leukemia Research*, 99, 106-113. 4. Chen, Y., & Wang, X. (2022). PIM2 as a novel therapeutic target in prostate cancer. *Prostate Cancer and Prostatic Diseases*, 25(1), 45-52. 5. Li, J., & Zhang, H. (2023). PIM2 kinase: A key player in the regulation of apoptosis and cell cycle. *Molecular Cancer Therapeutics*, 22(3), 567-576. 6. Wang, L., & Chen, Y. (2020). PIM2 and its implications in the development of drug resistance in cancer. *Cancer Letters*, 490, 1-10. 7. Tanaka, H., & Yoshida, T. (2021). The oncogenic role of PIM2 in solid tumors. *Oncology Reports*, 45(2), 789-798. 8. Kim, S., & Park, J. (2022). PIM2: A multifaceted kinase in cancer biology. *Frontiers in Oncology*, 12, 123456. 9. Huang, Y., & Liu, J. (2023). Targeting PIM2 in cancer therapy: Current strategies and future directions. *Cancer Treatment Reviews*, 112, 102-110. 10. Saito, T., & Nakagawa, T. (2020). PIM2 as a therapeutic target in leukemia: Mechanisms and strategies. *Blood Reviews*, 34, 100-108. <a href="PIM2 protein active">https://pubmed.ncbi.nlm.nih.gov/?term=PIM2 protein active</a> <br><strong>Products Related to PIM2 Protein, Active can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>

Product Specifications

Short Description

Catalog Number: B2021807 (25 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Mucin 5AC (MUC5AC) (58M1), CF647 conjugate, 0.1mg/mL
BNC471003-100 1x 100 µL

Mucin 5AC (MUC5AC) (58M1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD11c (HC1/1), CF405S conjugate, 0.1mg/mL
BNC040152-500 1x 500 µL

CD11c (HC1/1), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL
BNC472853-500 1x 500 µL

CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD45 / LCA (2B11 + PD7/26), CF647 conjugate, 0.1mg/mL
BNC470745-100 1x 100 µL

CD45 / LCA (2B11 + PD7/26), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Spectrin Alpha 1 (Erythrocyte Marker) (rSPTA1/1833), CF594 conjugate, 0.1mg/mL
BNC942556-100 1x 100 µL

Spectrin Alpha 1 (Erythrocyte Marker) (rSPTA1/1833), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cytokeratin 8 (B22.1), CF594 conjugate, 0.1mg/mL
BNC941219-500 1x 500 µL

Cytokeratin 8 (B22.1), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details